Results per Page:
Engineering B cells to improve HIV treatments
From the Kiem lab, Translational Sciences and Therapeutics Division
Stealing a base from cancer: precision editing for safer immunotherapy
From the Kiem Lab, Translational Science and Therapeutics Division
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Hitting ‘undo’ to cure Sickle Cell Disease
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy
From the Kiem Lab, Clinical Research Division
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy
After serving 1 year as vice president, Kiem will serve as president-elect and president of the society
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
Gene-modified cells in the brain
From the Kiem Lab, Clinical Research Division
Making a monkey out of MISTRG mice
From the Rongvaux Laboratory, Clinical Research Division
Genetically modified cells secrete HIV neutralizing antibodies
From the Kiem Lab, Clinical Research Division
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Taking the good out of viruses to cure immunodeficiencies by in vivo gene therapy
from the Kiem lab, Clinical Research Division
One step closer to the Berlin Patient and an HIV cure
Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award
Celebrating faculty and staff achievements
Fred Hutch HIV cure program extended, expanded
DefeatHIV receives second five-year grant from NIH to research gene and cell therapies
Good News at Fred Hutch
Celebrating faculty and staff achievements
Dr. Lily Selim receives inaugural CTI BioPharma International Postdoctoral Research Fellowship
Pediatric hematologist/oncologist studies new ways to detect and manage early leukemia relapse in children
Better help for menopausal women
New study focuses on best treatments for vaginal symptoms